| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.440 | 34.563 | 47.685 | 26.935 | 45.136 | 55.957 | 43.398 | 64.846 | 69.593 | 102.704 |
| Total Income - EUR | 10.440 | 34.563 | 47.685 | 26.935 | 45.136 | 55.957 | 43.398 | 64.846 | 69.593 | 102.704 |
| Total Expenses - EUR | 4.337 | 26.039 | 59.005 | 40.387 | 38.530 | 41.770 | 30.901 | 54.581 | 55.133 | 68.827 |
| Gross Profit/Loss - EUR | 6.103 | 8.524 | -11.320 | -13.452 | 6.606 | 14.187 | 12.497 | 10.266 | 14.460 | 33.877 |
| Net Profit/Loss - EUR | 5.790 | 7.576 | -11.797 | -13.721 | 5.939 | 12.833 | 11.221 | 8.901 | 13.868 | 30.950 |
| Employees | 1 | 1 | 2 | 2 | 1 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Transmed Center Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 973 | 618 | 275 | 0 | 0 | 0 |
| Current Assets | 21.157 | 8.250 | 344 | 319 | 138 | 2.285 | 5.680 | 15.052 | 22.951 | 32.427 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.474 | 21.974 | 17.044 |
| Cash | 21.157 | 8.250 | 344 | 319 | 138 | 2.285 | 5.680 | 8.578 | 977 | 15.383 |
| Shareholders Funds | 20.984 | 7.637 | -11.732 | -25.238 | -18.810 | -5.621 | 5.725 | 14.645 | 22.086 | 31.061 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 42 | 42 |
| Debts | 173 | 613 | 12.076 | 25.557 | 19.921 | 8.524 | 230 | 407 | 865 | 1.366 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Transmed Center Srl